🇰🇷 Naphcon Forte in South Korea

Naphcon Forte (NAPHAZOLINE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Naphcon Forte in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Ophthalmology approved in South Korea

Frequently asked questions

Is Naphcon Forte approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Naphcon Forte in South Korea?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.